GTS5:Volunteer Assignments and Opportunities - Revision history

Kgeiersbach: Removed Hieu Nguyen, since only Parisa Kargaran is working on these pages in Chapter 6.

2026-01-21T15:47:41Z

Removed Hieu Nguyen, since only Parisa Kargaran is working on these pages in Chapter 6.

← Older revision		Revision as of 10:47, 21 January 2026
Line 993:		Line 993:
	\|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)\|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]		\|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)\|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
	\|Disease		\|Disease
	\|Parisa Kargaran~~, Hieu Nguyen~~		\|Parisa Kargaran
	\|1/21/2026		\|1/21/2026
	\|		\|
Line 1,004:		Line 1,004:
	\|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)\|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]		\|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)\|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
	\|Disease		\|Disease
	\|Parisa Kargaran~~, Hieu Nguyen~~		\|Parisa Kargaran
	\|1/21/2026		\|1/21/2026
	\|		\|

Jennelleh at 14:36, 21 January 2026

2026-01-21T14:36:56Z

← Older revision		Revision as of 09:36, 21 January 2026
Line 993:		Line 993:
	\|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)\|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]		\|[[GTS5:Dyskeratosis_congenita_(DKC1,_TERT,_TERC,_TINF2,_Other_IBMFS_genes)\|Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
	\|Disease		\|Disease
			\|Parisa Kargaran, Hieu Nguyen
			\|1/21/2026
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Katherine Geiersbach
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, HAN5.		\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, HAN5.
Line 1,004:		Line 1,004:
	\|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)\|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]		\|[[GTS5:POT1_and_Shelterin-related_tumour_predisposition_syndrome_(POT1,_ACD,_TERF2IP,_TERT_promoter)\|POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
	\|Disease		\|Disease
			\|Parisa Kargaran, Hieu Nguyen
			\|1/21/2026
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Katherine Geiersbach
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.

Jennelleh at 14:44, 20 January 2026

2026-01-20T14:44:17Z

← Older revision		Revision as of 09:44, 20 January 2026
Line 408:		Line 408:
	\|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)\|Tuberous sclerosis (TSC1, TSC1)]]		\|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)\|Tuberous sclerosis (TSC1, TSC1)]]
	\|Disease		\|Disease
			\|Faisel Ibrahim
			\|1/20/2026
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5.

Kgeiersbach at 00:16, 17 January 2026

2026-01-17T00:16:15Z

← Older revision		Revision as of 19:16, 16 January 2026
Line 727:		Line 727:
	\|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)\|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]		\|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)\|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
	\|Disease		\|Disease
	\|~~Hieu Nguyen~~		\|Parisa Kargaran
	\|9/~~23/2025~~		\|1/9/26
	\|		\|1/16/2026
	\|~~PENDING~~		\|COMPLETE
	\|		\|
	\|Katherine Geiersbach		\|Katherine Geiersbach
Line 738:		Line 738:
	\|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)\|PALB2-related cancer predisposition syndrome (PALB2)]]		\|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)\|PALB2-related cancer predisposition syndrome (PALB2)]]
	\|Disease		\|Disease
	\|Hieu Nguyen		\|Parisa Kargaran, Hieu Nguyen
	\|9/23/2025		\|9/23/2025
	\|		\|1/16/2026
	\|~~PENDING~~		\|COMPLETE
	\|		\|
	\|Katherine Geiersbach		\|Katherine Geiersbach

Jennelleh at 14:30, 16 December 2025

2025-12-16T14:30:56Z

← Older revision		Revision as of 09:30, 16 December 2025
Line 826:		Line 826:
	\|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)\|Ataxia-telangiectasia syndrome (ATM)]]		\|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)\|Ataxia-telangiectasia syndrome (ATM)]]
	\|Disease		\|Disease
			\|Emilie Lalonde
			\|12/16/2025
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Katherine Geiersbach (Eric McGinnis as needed)
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO HAEM5, HAN5, FEM5, BRST5.		\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO HAEM5, HAN5, FEM5, BRST5.

Jennelleh at 14:59, 9 December 2025

2025-12-09T14:59:55Z

← Older revision		Revision as of 09:59, 9 December 2025
Line 648:		Line 648:
	\|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)\|CDK4-related melanoma predisposition syndrome (CDK4)]]		\|[[GTS5:CDK4-related_melanoma_predisposition_syndrome_(CDK4)\|CDK4-related melanoma predisposition syndrome (CDK4)]]
	\|Disease		\|Disease
			\|Xiaolin Hu
			\|12/9/2025
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
Line 749:		Line 749:
	\|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)\|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]		\|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)\|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
	\|Disease		\|Disease
			\|Xiaolin Hu
			\|12/9/2025
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.

Jasmine.Baker: Added target completion date

2025-10-08T17:55:46Z

Added target completion date

← Older revision		Revision as of 12:55, 8 October 2025
Line 322:		Line 322:
	\|Jasmine Baker, PhD		\|Jasmine Baker, PhD
	\|08/25/2025		\|08/25/2025
	\|		\|12/31/2025
	\|		\|
	\|		\|

Richard.Glen: Formatted Author Names

2025-09-24T21:37:02Z

Formatted Author Names

← Older revision		Revision as of 16:37, 24 September 2025
Line 130:		Line 130:
	\|[[GTS5:Neurofibromatosis_type_1_(NF1)\|Neurofibromatosis type 1 (NF1)]]		\|[[GTS5:Neurofibromatosis_type_1_(NF1)\|Neurofibromatosis type 1 (NF1)]]
	\|Disease		\|Disease
	\|Ngoni Faya (trainee) + Madina Sukhanova		\|Ngoni Faya (trainee);
			Madina Sukhanova
	\|7/12/2023		\|7/12/2023
	\|		\|

Jennelleh at 15:56, 23 September 2025

2025-09-23T15:56:31Z

← Older revision		Revision as of 10:56, 23 September 2025
Line 726:		Line 726:
	\|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)\|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]		\|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)\|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
	\|Disease		\|Disease
			\|Hieu Nguyen
			\|9/23/2025
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Katherine Geiersbach
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5, FEMA5.		\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5, FEMA5.
Line 737:		Line 737:
	\|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)\|PALB2-related cancer predisposition syndrome (PALB2)]]		\|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)\|PALB2-related cancer predisposition syndrome (PALB2)]]
	\|Disease		\|Disease
			\|Hieu Nguyen
			\|9/23/2025
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Katherine Geiersbach
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5.		\|Named based on GTS5 book. GTS-Specific Template (11-7-24) added 12/29/24 to page created on 7/12/24. Also, content in online WHO BRST5.

Jennelleh at 15:18, 23 September 2025

2025-09-23T15:18:13Z

← Older revision		Revision as of 10:18, 23 September 2025
Line 242:		Line 242:
	\|[[GTS5:AXIN2-associated_polyposis_(AXIN2)\|AXIN2-associated polyposis (AXIN2)]]		\|[[GTS5:AXIN2-associated_polyposis_(AXIN2)\|AXIN2-associated polyposis (AXIN2)]]
	\|Disease		\|Disease
			\|Suhasini Lulla (trainee working with Eric as mentor)
			\|9/23/25
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.
Line 603:		Line 603:
	\|[[GTS5:Retinoblastoma_syndrome_(RB1)\|Retinoblastoma syndrome (RB1)]]		\|[[GTS5:Retinoblastoma_syndrome_(RB1)\|Retinoblastoma syndrome (RB1)]]
	\|Disease		\|Disease
			\|Suhasini Lulla (trainee working with Eric as mentor)
			\|9/23/25
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, PEDS5, CNS5.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5, PEDS5, CNS5.
Line 625:		Line 625:
	\|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)\|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]		\|[[GTS5:CDKN2A-related_tumour_predisposition_syndrome_(CDKN2A)\|CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
	\|Disease		\|Disease
			\|Suhasini Lulla (trainee working with Eric as mentor)
			\|9/23/25
	\|		\|
			\|PENDING
	\|		\|
	\|		\|Eric McGinnis
	\|
	\|
	\|
	\|		\|
	\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.		\|Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content.